Search results for " Character"

showing 10 items of 1756 documents

Is Participation in Tourism Market an Opportunity for Everyone? Some Evidence from Italy

2014

Exploring the main determinants of tourism participation at national and international level, the paper investigates if there are differences in tourism consumption behavior among Italian families which reflect disparities in their standard of living. To achieve this a Heckman model has been used on a huge sample of Italian households over the period 1997-2007. Results show that participation in the tourism market is strongly affected by the personal characteristics of individuals and that tourism consumption is an income sensitive good. The analysis reveals that tourism is generally a luxury good reflecting the disparities in the standard of living among Italian families. We have found tha…

Domestic and Intervational Travel Standard of LivingSettore SECS-S/03 - Statistica EconomicaTourism ConsumptionIncome ElasticityHousehold Characteristic
researchProduct

Drug gastrointestinal absorption in rat: Strain and gender differences.

2015

Predictive animal models of intestinal drug absorption are essential tools in drug development to identify compounds with promising biopharmaceutical properties. In situ perfusion absorption studies are routinely used in the preclinical setting to screen drug candidates. The objective of this work is to explore the differences in magnitude and variability on intestinal absorption associated with rat strain and gender. Metoprolol and Verapamil absorption rate coefficients were determined using the in situ closed loop perfusion model in four strains of rats and in both genders. Strains used were Sprague-Dawley, Wistar-Han, Wistar-Unilever, Long-Evans and CD∗IGS. In the case of Metoprolol only…

DrugAbsorption (pharmacology)Malemedia_common.quotation_subjectPharmaceutical SciencePharmacologyIntestinal absorptionRats Sprague-DawleySpecies SpecificitymedicineAnimalsRats Long-EvansRats Wistarmedia_commonMetoprololSex CharacteristicsIntestinal permeabilityChemistrymedicine.diseaseIntestinal AbsorptionVerapamilPermeability (electromagnetism)VerapamilFemalePerfusionmedicine.drugMetoprololEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
researchProduct

Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources.

2006

Aims To compare information on drug–drug interactions (DDIs) reported on two standard drug-related information sources (Summary of Product Characteristics and Drugdex system by Micromedex), by assessing the prevalence and predictors of potential DDI with proton pump inhibitors (PPIs) in general practice. Methods From the ‘Caserta-1’ Local Health-Service database, 156 general practitioners (GPs) were recruited. From more than 180 000 individuals registered on their lists, we selected patients receiving co-prescription of PPI and medications at interaction risk, according to the Italian Summary of Product Characteristics (SPC) of PPI and Drugdex information, during the year 2003. Thereafter, …

DrugAdultMalemedicine.medical_specialtyAdolescentmedia_common.quotation_subjectPharmacology toxicologyToxicologyDrugdexDrug PrescriptionsInternal medicineEpidemiologymedicineHumansPharmacology (medical)Drug InteractionsSummary of Product CharacteristicsRisk factorMedical prescriptiondrug information sourcesSummary of Product Characteristicsmedia_commonAgedgeneral practicePharmacologyAged 80 and overObserver VariationDrug pairbusiness.industryPharmacoepidemiologydrug information sources Drugdex drug–drug interaction general practice proton pump inhibitors Summary of Product CharacteristicsRegression analysisProton Pump InhibitorsDrug interactionMiddle Ageddrug information sources; Drugdex; drug-drug interaction; general practice; proton pump inhibitors; Summary of Product CharacteristicsSpontaneous reportingFamily medicineDrug Information ServicesInformation sourceFemalebusinessFamily Practicedrug-drug interactionBritish journal of clinical pharmacology
researchProduct

Duloxetine serum concentrations and clinical effects. Data from a therapeutic drug monitoring (TDM) survey.

2009

INTRODUCTION The aim of this study was to relate drug concentrations in serum and clinical effects in patients treated with the new antidepressant duloxetine. METHODS Data were obtained from a newly established therapeutic drug monitoring (TDM) survey. Duloxetine was measured using HPLC with UV detection and clinical effects by the clinical global impressions (CGI) scale for improvement. RESULTS The study included 103 depressed inpatients (69% female). Patients under duloxetine monotherapy who were very much improved according to CGI had significantly (p<0.05) higher serum levels than patients with moderate, minimal or lacking improvement (mean+/-SD and range, 93+/-53 ng/mL and 30-182 ng/mL…

DrugAdultMalemedicine.medical_specialtyUltraviolet Raysmedia_common.quotation_subjectUrologyThiophenesPharmacologyDuloxetine HydrochlorideDuloxetine HydrochlorideSeverity of Illness Indexchemistry.chemical_compoundYoung AdultSeverity of illnessMedicineDuloxetineHumansPharmacology (medical)Chromatography High Pressure Liquidmedia_commonAgedAged 80 and overDepressive DisorderReceiver operating characteristicmedicine.diagnostic_testDose-Response Relationship Drugbusiness.industrySpectrum AnalysisGeneral MedicineSerum concentrationMiddle AgedAntidepressive AgentsPsychiatry and Mental healthDose–response relationshipTreatment OutcomechemistryROC CurveTherapeutic drug monitoringFemaleDrug MonitoringbusinessPharmacopsychiatry
researchProduct

Predicting the risk of drug–drug interactions in psychiatric hospitals: a retrospective longitudinal pharmacovigilance study

2021

ObjectivesThe aim was to use routine data available at a patient’s admission to the hospital to predict polypharmacy and drug–drug interactions (DDI) and to evaluate the prediction performance with regard to its usefulness to support the efficient management of benefits and risks of drug prescriptions.DesignRetrospective, longitudinal study.SettingWe used data from a large multicentred pharmacovigilance project carried out in eight psychiatric hospitals in Hesse, Germany.ParticipantsInpatient episodes consecutively discharged between 1 October 2017 and 30 September 2018 (year 1) or 1 January 2019 and 31 December 2019 (year 2).Outcome measuresThe proportion of rightly classified hospital epi…

DrugHospitals PsychiatricLongitudinal studymedicine.medical_specialtymedia_common.quotation_subjectHealth informaticslaw.invention03 medical and health sciencesPharmacovigilance0302 clinical medicinelawRisk FactorsGermanyPharmacovigilanceMedicineHumans1723Drug Interactions030212 general & internal medicine1506Longitudinal StudiesMedical prescriptionPsychiatryhealth informaticsmedia_commonRetrospective StudiesPolypharmacyClinical pharmacologyReceiver operating characteristicbusiness.industryRGeneral MedicinePharmacology and Therapeuticspsychiatry030227 psychiatryPharmaceutical PreparationsMedicineclinical pharmacologybusinessBMJ Open
researchProduct

Gender difference in drug use in hospitalized elderly patients.

2015

Purpose The aims of this study were to evaluate whether or not there are gender differences in drug use at hospital admission and prescription at discharge and to evaluate the effect of hospitalization on medication patterns in the elderly. Method In-patients aged &gt; 65 years included in the REPOSI registry during a recruitment period of 3 years (2008-2010-2012) were analyzed in order to evaluate drug use at hospital admission and prescription at discharge according to gender. Results A total of 3473 patients, 52% women and 48% men, were considered. Polypharmacy (&gt; 5 drugs) is more frequent in men both at hospital admission and discharge. At hospital discharge, the number of prescripti…

DrugMalePediatricsmedicine.medical_specialtySettore MED/09 - Medicina Internamedia_common.quotation_subjectSocio-culturaleDrug Prescriptionselderly gender polypharmacyElderlyAge groupsDrug PrescriptionHospital dischargeInternal MedicineMedicineHumansMedical prescriptionSex DistributionPrescribed drugsmedia_commonAgedElderly; Gender; Polypharmacy; Internal MedicinePolypharmacyAged 80 and overSex Characteristicsbusiness.industryGenderSex CharacteristicPatient DischargeHospitalizationHospital admissionPolypharmacyFemalebusinessSex characteristicsHumanEuropean journal of internal medicine
researchProduct

Improving Pattern Recognition Based Pharmacological Drug Selection Through ROC Analysis

2004

The design of new medical drugs is a very complex process in which combinatorial chemistry techniques are used. The goal consists of discriminating between molecular compounds exhibiting or not certain pharmacological activities. Different machine learning approaches have been recently applied to different drug design problems leading to competitive results in pointing at particular compounds with high probability of exhibiting activity. The present work first deeps into the natural trade-off between accuracy in the much less populated active group and false alarm rate which could lead to too many expensive laboratory tests. Preliminary results show how different classification techniques a…

DrugReceiver operating characteristicCombinatorial Chemistry TechniquesComputer sciencebusiness.industryProcess (engineering)media_common.quotation_subjectMachine learningcomputer.software_genrePattern recognition (psychology)Artificial intelligencebusinesscomputerSelection (genetic algorithm)media_common
researchProduct

Biowaiver Monographs for Immediate Release Solid Oral Dosage Forms: Cephalexin Monohydrate.

2019

Literature data and results of experimental studies relevant to the decision to allow waiver of bioequivalence studies in humans for the approval of immediate release solid oral dosage forms containing cephalexin monohydrate are presented. Solubility studies were performed in accordance with the current biowaiver guidelines of the Food and Drug Administration, World Health Organization and European Medicines Agency, taking the degradation at some pH values into consideration. Together with solubility and permeability data for cephalexin monohydrate from the literature, it was demonstrated to be a Biopharmaceutics Classification System Class 1 drug. The pharmacokinetic behavior, results of b…

Drugmedia_common.quotation_subjectPharmaceutical ScienceExcipientAdministration OralBiological Availability02 engineering and technologyBioequivalencePharmacology030226 pharmacology & pharmacyDosage formPermeabilityBiopharmaceutics03 medical and health sciences0302 clinical medicinemedicineBiopharmaceutics Classification System (BCS)HumansRegulatory scienceLADME characteristicsmedia_commonActive ingredientcephalexin monohydrateDosage FormsbioequivalenceCephalexinexcipientsbusiness.industryBiopharmaceutics021001 nanoscience & nanotechnologyBiopharmaceutics Classification SystemSolubilityTherapeutic Equivalencyregulatory science0210 nano-technologybusinessmedicine.drugJournal of pharmaceutical sciences
researchProduct

Safety of the current drug treatments for vitiligo

2020

Introduction: Vitiligo is an acquired depigmenting skin disorder adversely affecting the patient's quality of life. Despite the presence of several treatment modalities, ranging from medical to physical to surgical options, none is curative. Each modality has its own drawbacks and side effects. Thus, the treatment modality needs to be tailored for each individual patient taking into consideration the disease characteristics and also its efficacy and safety to obtain a favorable risk-benefit ratio.Areas covered: This review highlights the different treatment modalities utilized in vitiligo up until 4 November 2019 along with their adverse effects and contraindications, if any.Expert opinion:…

Drugmedicine.medical_specialtymedia_common.quotation_subjectVitiligoVitiligo030204 cardiovascular system & hematologyAdministration Cutaneous03 medical and health sciences0302 clinical medicineQuality of life (healthcare)Adrenal Cortex HormonesmedicineHumansEffective treatmentPharmacology (medical)Intensive care medicineAdverse effectmedia_commonBiological ProductsModality (human–computer interaction)business.industryGeneral Medicinemedicine.diseaseTreatment modality030220 oncology & carcinogenesisQuality of LifeDisease characteristicsDermatologic AgentsbusinessExpert Opinion on Drug Safety
researchProduct

Electro-optical characterization of ruthenium-based dye sensitized solar cells: A study of light soaking, ageing and temperature effects

2017

Abstract In this work, we report on the electro-optical characterization of Dye Sensitized Solar Cells (DSSCs) which use ruthenium complexes as sensitizers. In particular, several kinds of measurements have been performed to study the electrical performances and the efficiency levels of the cells at different operating conditions. In detail, the measurements have been conducted at varying temperatures and hours of light soaking. Our results show that the short circuit current density J SC , the open circuit voltage V OC and the conversion efficiency η increase with the hours of light soaking, while they decrease with temperature. A thorough investigation on the light soaking process at the …

Dye sensitized solar cells (DSSCs)FabricationMaterials sciencechemistry.chemical_element02 engineering and technology010402 general chemistry01 natural sciencesSettore ING-INF/01 - ElettronicaPhotovoltaicsElectrical and Electronic Engineeringbusiness.industryOpen-circuit voltageEnergy conversion efficiencySettore ING-INF/02 - Campi ElettromagneticiLight soaking021001 nanoscience & nanotechnologyElectro-optical characterizationsAtomic and Molecular Physics and Optics0104 chemical sciencesElectronic Optical and Magnetic MaterialsRutheniumCharacterization (materials science)Dye-sensitized solar cellchemistryOptoelectronics0210 nano-technologybusinessShort circuitPhotovoltaic
researchProduct